This immersive program is tailored for professionals seeking to enhance their knowledge and skills in the dynamic pharmaceutical sector.
With approximately 40 hours of sessions of expert-led instruction, 14 modules and 10 hours of collaborative group work, participants will delve into crucial topics such as Strategy, Research & Development, Operations, Future Healthcare Trends, and Sustainability.
Taking place on Fridays and Saturdays, this executive course started on March 21st and will finish on May 31st, with half of the sessions held at the Católica Medical School and the other half at Hospital da Luz Lisboa.
Participants will explore these themes through interactive business case studies and practical sessions, gaining valuable insights into the complexities of the industry.
This edition will feature speakers such as Paulo Teixeira, Country Manager at Pfizer Portugal; Tarkan Dogru, Head Technical Development Synthetic Molecules at Roche; Hugo Barbosa, EU Customer Omnichannel Director at ViiV Healthcare; Paula Martins de Jesus, Medical Director at MSD; Paula Rosa, Senior Director Product Strategy at Roche; Teresa Guerreiro, Market Access, Pricing & HTA Senior Consultant; Filipa Mota e Costa, Managing Director at J&J Innovative Medicine Portugal; André de Aragão Azevedo, Member of ESNA Advisory Board; Paulo Barradas Rebelo, President at Bluepharma; Sofia Ferreira, Managing Director at Organon Portugal; André Correia, Executive VP at SERaro.pt e Sérgio Alves, Global Head of Health Equity at AstraZeneca.
There is still time to join the Global Pharma course!
Participants can enroll in individual modules or opt for the second part of the program which will be conducted entirely at Hospital da Luz.
Registrations here: https://www.thegenh.com/gp3
Don’t miss this incredible opportunity to dive into the world of the pharmaceutical industry!
For more information, please contact: Daniel Guedelha (dguedelha@ucp.pt), info@cac-cl.pt or visit https://cac-cl.pt/services/global-pharmaceutical-industry-executive-course/.
